Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Esperion Therapeutics, Inc. | ESPR

Daily Technical Analysis of Esperion Therapeutics, Inc.

Esperion Therapeutics is down a bit on the day, funds flowing out kept the price down -1.30% since yesterday.

Currently ESPR isn't at a clear support/resistance line that seems tradable. Momentum wise Esperion Therapeutics, has been oscillating up and down but hasn't shown much directional energy that would be predictive to the near future. ESPR might find some support at the 4.91 level, buyers might push the price back up from here. But it's not very clear what will happen.


Analyst Ratings for Esperion Therapeutics By Price Target And Rating

Analysts currently have an extremely positive outlook for Esperion Therapeutics. This normally relates to positive future price increases, especially on pullbacks. The current Analysts Sentiment Score is 413.35. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Credit Suisse Group upgraded from Underperform to Neutral on 2023-03-07 and also increased their price target by 7.69% to $7.00. Needham & Company LLC boosted their price targ by 33.33% to $16.00 on 2023-03-06. JMP Securities reiterated a rating of Market Outperform on 2023-03-06 and added a price target of $15.00. On 2023-03-06 HC Wainwright reiterated their rating of Buy and added a price target of $22.00. JPMorgan Chase & Co. provided a price target boost of 12.5% to $9.00 from $8.00 on 2023-02-27. Bank of America announced that they are initiating coverage with a rating of Neutral on 2023-02-27 and added a price target of $8.00. Jefferies Financial Group upgraded from Hold to Buy on 2023-02-24 and provided a price target of $12.00. On 2023-02-03 Morgan Stanley upgraded Esperion Therapeutics from Underweight to Equal Weight and added a price target of $9.00. Cowen dropped their 1 year price target to 13.00 on 2022-08-09. Northland Securities announced a lowering of their price target to $5.00 from $10.00 on 2022-01-12.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
ESPR413.35390.12-0.45439.35-2.32

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2022-11-28)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
ESPR25.623.46

Short interest for Esperion Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
ESPR18.62%22.917311.611.35214030000

How Esperion Therapeutics compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Biotechnology

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
3671.85-0.88-10.561.85-7.04-22.1531.57-13.77-17.27-13.81-41814.93-3164.240.9521.196.5448.84
Healthcare

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
6172.00-0.17-8.492.07-6.13-23.9331.85-11.33-14.45-14.07-36805.91-4054.411.0522.335.9336.37

Social Sentiment for Esperion Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
ESPR6.00

Companies with the highest correlation to Esperion Therapeutics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
SGMO | Sangamo Therapeutics, Inc0.6-1.55-12.04-34.71-39.49-64.15-67.139-49.80-90.58-41.56-39882.110.00008.30077
VSTM | Verastem, Inc.0.55-0.554.65-9.7822.52-59.82-64.5733-19.68-16.20-41.48-27441.70-671.28000.893001
VKTX | Viking Therapeutics, Inc0.54-19.35-12.17-14.6515.95205.54188.623293.72128.46106.04-2064.43-23764.37001.84923
NLTX | Neoleukin Therapeutics, I0.51-1.047.5830.7857.05-28.59-65.4469-12.13-16.52-34.10-50525.76-2435.3110001.12557
DTIL | Precision BioSciences, In0.472.41-5.49-24.11-15.00-39.29-72.1321-34.87-47.02-69.92-42080.500.00002.74608
PGEN | Precigen, Inc. Common Sto0.476.86-0.91-14.84-23.24-59.33-48.1033-33.05-47.44-28.31-26737.410.00007.49073
PBYI | PUMA BIOTECHNOLOGY INC0.461.623.72-38.33-49.700.80-18.773-2.002.6715.19-11770.08-1129.20003.89645
ARQT | Arcutis Biotherapeutics, 0.46-0.094.05-27.16-18.88-39.89-29.903-30.39-46.50-24.89-28817.240.000020.1348

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-